Hyung Kyu Lim

Title: The Innovations of Hyung Kyu Lim

Introduction

Hyung Kyu Lim is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of long-acting protein formulations. With a total of 13 patents to his name, Lim's work has the potential to impact various therapeutic applications.

Latest Patents

One of Lim's latest patents is a lyophilized formulation of a long-acting human growth hormone immunoglobulin conjugate. This invention discloses a sustained release preparation that includes a human growth hormone conjugate, a buffer solution, a nonionic surfactant, and a sugar alcohol. The patent also details a freeze-dried preparation and a liquid preparation that includes the sustained release human growth hormone conjugate, along with methods for production and reconstitution.

Another notable patent is a liquid formulation of a long-lasting protein conjugate comprising oxyntomodulin and an immunoglobulin Fc region. This invention relates to an albumin-free liquid formulation that enhances the duration of physiological activity and maintains in vivo stability. The formulation is designed to be free from human serum albumin and potentially harmful factors, thus reducing the risk of viral infection.

Career Highlights

Hyung Kyu Lim has worked with notable companies such as Hanmi Pharmaceutical Co., Ltd. and Hanmi Science Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative biopharmaceutical products.

Collaborations

Lim has collaborated with several professionals in his field, including Se Chang Kwon and Sung Min Bae. These collaborations have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Hyung Kyu Lim's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work in developing long-acting protein formulations holds promise for improving therapeutic outcomes in various medical conditions.